Komori
M&A and Subsidiary Changes3386COSMO BIO COMPANY,LIMITEDTrading & Wholesale

Notice Regarding the Making of Consolidated Subsidiary BM Kiki Co., Ltd. a Wholly Owned Subsidiary Through a Simplified Share Exchange

COSMO BIO COMPANY, LIMITED will acquire the remaining shares of its consolidated subsidiary BM Kiki Co., Ltd., in which it holds 67.82% of the voting rights, through a share exchange and make it a wholly owned subsidiary. As consideration, it plans to deliver 114,716 treasury shares to Tokyo Small and Medium Business Investment & Consultation Co., Ltd.

Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
114716
Shares
Wording
Conditional
How definitive the wording is.

This transaction

This share exchange
Counterparty (target company)ビーエム機器株式会社
Disclosing companyCOSMO BIO COMPANY,LIMITED
Voting rights ownership percentageNumber of shares acquired All issued shares of BM Kiki, excluding those held by the company. The number of shares is not disclosed. Number of voting rights: Not disclosed.

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.White points represent dates designated as scheduled dates in the document.
Target company

Purchasing, wholesale and sale of equipment and consumables for life sciences research, and technical support

Location Koto-ku, TokyoShare capital Capital of target companyDate of incorporation June 1985
Net Sales¥2,118 million (fiscal year ended December 2025)
Operating profit¥66 million (fiscal year ended December 2025)
Net income for the current fiscal yearNet loss of ¥12 million (fiscal year ended December 2025)
Net assets¥1,411 million (fiscal year ended December 2025)
Consideration and expenses
Type of ConsiderationShares. The company plans to allot and deliver 114,716 of its common shares to Tokyo Small and Medium Business Investment & Consultation Co., Ltd. All shares to be delivered will be treasury shares, and no new shares are scheduled to be issued.
Merger ratio/share exchange ratioThe company (share exchange wholly owning parent company) 1 : BM Kiki (share exchange wholly owned subsidiary) Class 1 preferred shares 4.82. For each Class 1 preferred share of BM Kiki, 4.82 common shares of the company will be delivered.
Funding arrangements114,716 of the 350,079 treasury shares held by the company will be allocated. No new shares are scheduled to be issued.
Impact on Business Performance

As BM Kiki is already a consolidated subsidiary of the company, the company expects the impact of this share exchange on its consolidated financial results to be immaterial.

Procedures and assumptions
Valuation methodologyThe company: market price method; BM Kiki: DCF method and comparable company analysis method.
Independent valuation institutionNarahara Certified Public Accountant Office
Conditions Precedent to ExecutionApproval at BM Kiki's extraordinary general meeting of shareholders and Class 1 preferred shareholders' meeting. The company plans to make shareholder approval unnecessary through a simplified share exchange, but the schedule may change if approval becomes necessary under Article 796, Paragraph 3 of the Companies Act.
Management structure after acquisitionThere will be no changes to the company's name, location, representative's title or name, business activities, stated capital or fiscal year-end following the share exchange. Employee treatment: Not disclosed.
This transaction
ItemDetails
Transaction nameThis share exchange
Counterparty nameビーエム機器株式会社
Name of the Subject Companyビーエム機器株式会社
Business Description of the Subject CompanyPurchasing, wholesale and sale of equipment and consumables for life sciences research, and technical support
Location of the Subject CompanyKoto-ku, Tokyo
Capital Stock of the Subject CompanyCapital of target company
Date of Establishment of the Subject CompanyJune 1985
Net Sales of the Subject Company¥2,118 million (fiscal year ended December 2025)
Operating Profit of the Subject Company¥66 million (fiscal year ended December 2025)
Net Income of the Subject CompanyNet loss of ¥12 million (fiscal year ended December 2025)
Net Assets of the Subject Company¥1,411 million (fiscal year ended December 2025)
Type of ConsiderationShares. The company plans to allot and deliver 114,716 of its common shares to Tokyo Small and Medium Business Investment & Consultation Co., Ltd. All shares to be delivered will be treasury shares, and no new shares are scheduled to be issued.
Merger ratio/share exchange ratioThe company (share exchange wholly owning parent company) 1 : BM Kiki (share exchange wholly owned subsidiary) Class 1 preferred shares 4.82. For each Class 1 preferred share of BM Kiki, 4.82 common shares of the company will be delivered.
Number of shares acquiredAll issued shares of BM Kiki, excluding those held by the company. The number of shares is not disclosed. Number of voting rights: Not disclosed.
Voting rights ownership percentageBefore 67.82% → after 100%
Funding arrangements114,716 of the 350,079 treasury shares held by the company will be allocated. No new shares are scheduled to be issued.
Impact on Business PerformanceAs BM Kiki is already a consolidated subsidiary of the company, the company expects the impact of this share exchange on its consolidated financial results to be immaterial.
Date of board resolutionBM Kiki: 18 November 2026; the company: 19 November 2026
Contract Date19 November 2026
Execution Date / Effective Date25 December 2026 (予定)
Valuation methodologyThe company: market price method; BM Kiki: DCF method and comparable company analysis method.
Independent valuation institutionNarahara Certified Public Accountant Office
Conditions Precedent to ExecutionApproval at BM Kiki's extraordinary general meeting of shareholders and Class 1 preferred shareholders' meeting. The company plans to make shareholder approval unnecessary through a simplified share exchange, but the schedule may change if approval becomes necessary under Article 796, Paragraph 3 of the Companies Act.
Management structure after acquisitionThere will be no changes to the company's name, location, representative's title or name, business activities, stated capital or fiscal year-end following the share exchange. Employee treatment: Not disclosed.
Items this document does not state (8)
Acquisition priceExpenses other than the acquisition priceTender offer priceMinimum number of shares to be purchasedTender offer periodGoodwill amountAmount of extraordinary income (loss)Special Committee

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To further enhance the corporate value of the Group by speeding up decision-making within the Group, improving efficiency through operational integration and strengthening business collaboration.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Making of Consolidated Subsidiary BM Kiki Co., Ltd. a Wholly Owned Subsidiary Through a Simplified Share Exchange | COSMO BIO COMPANY,LIMITED (3386) timely disclosure | Komori